[Infections and granulocyte colony-stimulating factor (G-CSF)].
Solovera
J J
JJ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology / Q000628:therapy*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D009503:Neutropenia / Q000628:therapy*; D009504:Neutrophils / Q000187:drug effects; D011014:Pneumonia / Q000188:drug therapy / Q000628:therapy; D011446:Prospective Studies; D011994:Recombinant Proteins; D012852:Sinusitis / Q000628:therapy; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000628:therapy
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim